Prostate Cancer Radiation Comparisons Support IMRT, Question Proton Therapy

A large Medicare database analysis provides support for intensity-modulated radiation therapy as the standard radiation tool for prostate cancer, while the nascent proton therapy showed no advantages.

More from Archive

More from Medtech Insight